Australia markets open in 9 hours 33 minutes

Sana Biotechnology, Inc. (SANA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.89-0.11 (-1.10%)
As of 10:27AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.21B
Enterprise value 2.11B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.70
Enterprise value/revenue N/A
Enterprise value/EBITDA -7.86

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 363.67%
S&P500 52-week change 325.77%
52-week high 312.00
52-week low 32.74
50-day moving average 39.20
200-day moving average 35.91

Share statistics

Avg vol (3-month) 32.12M
Avg vol (10-day) 31.85M
Shares outstanding 5221.32M
Implied shares outstanding 6231.06M
Float 8128.28M
% held by insiders 19.06%
% held by institutions 184.57%
Shares short (15 Apr 2024) 426.72M
Short ratio (15 Apr 2024) 419.99
Short % of float (15 Apr 2024) 425.20%
Short % of shares outstanding (15 Apr 2024) 412.07%
Shares short (prior month 15 Mar 2024) 424.68M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-29.44%
Return on equity (ttm)-72.00%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -302.34M
Net income avi to common (ttm)-283.26M
Diluted EPS (ttm)-1.46
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)205.2M
Total cash per share (mrq)0.93
Total debt (mrq)104.1M
Total debt/equity (mrq)36.21%
Current ratio (mrq)3.31
Book value per share (mrq)1.45

Cash flow statement

Operating cash flow (ttm)-253.58M
Levered free cash flow (ttm)-199.92M